Literature DB >> 27829878

Glanzmann thrombasthenia in pregnancy: Optimising maternal and fetal outcomes.

A Wijemanne1, I Watt-Coote1, S Austin2.   

Abstract

Glanzmann thrombasthenia is a rare autosomal recessive haemorrhagic disorder. The risks of miscarriage, antepartum and postpartum haemorrhage, and neonatal complications are all increased in individuals presenting with the disease in pregnancy. Some individuals may develop antibodies to platelet glycoproteins; the presence of these antibodies is a rare cause of neonatal alloimmune thrombocytopenia and potential intracranial haemorrhage. Multidisciplinary care is paramount for ensuring optimal fetal and maternal outcomes in such cases. We report a case of neonatal alloimmune thrombocytopenia secondary to maternal Glanzmann thrombasthenia in pregnancy.

Entities:  

Keywords:  Glanzmann thrombasthenia; High-risk pregnancy; haematology; haemorrhage; maternal-fetal medicine; neonatal alloimmune thrombocytopenia

Year:  2016        PMID: 27829878      PMCID: PMC5089344          DOI: 10.1177/1753495X16655021

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  13 in total

1.  Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature.

Authors:  Tahir Sultan Shamsi; Nazli Hossain; Nargis Soomro; Jahan Ara Hasan; Mehar Noorani; Sara Kazi; Mohammed Saeed Quraishy; Bilal Jameel; Syed Tipu Sultan; Saeeda Haider
Journal:  J Pak Med Assoc       Date:  2005-11       Impact factor: 0.781

Review 2.  Glanzmann's thrombasthenia: the spectrum of clinical disease.

Authors:  J N George; J P Caen; A T Nurden
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

Review 3.  Glanzmann's thrombasthenia in pregnancy: a case and review of the literature.

Authors:  D M Sherer; R Lerner
Journal:  Am J Perinatol       Date:  1999       Impact factor: 1.862

Review 4.  A systematic review of the management and outcomes of pregnancy in Glanzmann thrombasthenia.

Authors:  S Siddiq; A Clark; A Mumford
Journal:  Haemophilia       Date:  2011-04-04       Impact factor: 4.287

Review 5.  Pregnancy in mother with Glanzmann's thrombasthenia and isoantibody against GPIIb-IIIa: Is there a foetal risk?

Authors:  Nadia Léticée; Cécile Kaplan; Didier Lémery
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-08-01       Impact factor: 2.435

6.  The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.

Authors:  Ahmet Kale; Gokhan Bayhan; Ahmet Yalinkaya; Murat Yayla
Journal:  J Perinat Med       Date:  2004       Impact factor: 1.901

7.  Intravenous immunoglobulin g therapy in fetal and neonatal alloimmune thrombocytopenia.

Authors:  K P Dunsmore
Journal:  BioDrugs       Date:  1997-10       Impact factor: 5.807

8.  DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb/IIIa.

Authors:  S Lethagen; I M Nilsson
Journal:  Eur J Haematol       Date:  1992-07       Impact factor: 2.997

9.  Pregnancy in a patient of Glanzmann's thrombasthenia.

Authors:  Neena Malhotra; Charu Chanana; Deepika Deka
Journal:  Indian J Med Sci       Date:  2006-03

Review 10.  Glanzmann thrombasthenia.

Authors:  Alan T Nurden
Journal:  Orphanet J Rare Dis       Date:  2006-04-06       Impact factor: 4.123

View more
  3 in total

1.  Disease Burden in Patients with Glanzmann's Thrombasthenia: Perspectives from the Glanzmann's Thrombasthenia Patient/Caregiver Questionnaire.

Authors:  Alexander Duncan; Angela Kellum; Skye Peltier; David L Cooper; Hossam Saad
Journal:  J Blood Med       Date:  2020-09-11

2.  Menstrual and obstetrical bleeding in women with inherited platelet receptor defects-A systematic review.

Authors:  Marieke C Punt; Pauline C E Schuitema; Kitty W M Bloemenkamp; Idske C L Kremer Hovinga; Karin P M van Galen
Journal:  Haemophilia       Date:  2020-01-31       Impact factor: 4.287

3.  Glanzmann's thrombasthenia: a rare bleeding disorder in a Nigerian girl.

Authors:  Osita U Ezenwosu; Barth F Chukwu; Ndubuisi A Uwaezuoke; Ifeyinwa L Ezenwosu; Anthony N Ikefuna; Ifeoma J Emodi
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.